Reduction in Drug Prescription using Biofeedback Relaxation in Neurotic and Psychosomatic Disorders

Area of Science:

• Psychiatry
• Psychology
• Neuroscience

Background:

• Limited Indian research exists on biofeedback's effectiveness in reducing medication for neurotic and stress-related disorders.
• Neurotic and psychosomatic disorders encompass conditions like generalized anxiety disorder, mixed anxiety-depression, OCD, dissociative disorders, and headaches.

Purpose of the Study:

• To evaluate the effectiveness of biofeedback, pharmacotherapy, and their combination in managing neurotic and psychosomatic disorders in an Indian population.
• To assess the reduction in drug prescription and long-term outcomes for these conditions.

Main Methods:

• A study involved 78 patients diagnosed with anxiety and stress-related disorders, divided into three groups.
• Group 1 received pharmacotherapy, Group 2 received biofeedback, and Group 3 received both pharmacotherapy and biofeedback for 12 weeks.
• Follow-up assessments were conducted at six months and one year.

Main Results:

• The combination group (Group 3) showed the highest effectiveness, with 66.66% requiring no further treatment at one year.
• The biofeedback-only group (Group 2) showed improvement, with 17.39% requiring no follow-up, compared to 21.43% in the drug-therapy-only group (Group 1).
• The combination therapy resulted in significantly lower levels of mild and moderate anxiety compared to monotherapy.

Conclusions:

• Combining biofeedback with pharmacotherapy is effective for select neurotic and psychosomatic disorders.
• Biofeedback offers a viable complementary or alternative approach to reduce medication dependency in stress-related conditions.
• Further research is warranted to explore the long-term benefits and applicability across diverse patient populations.